icon-folder.gif   Conference Reports for NATAP  
 
  17th International Workshop
on Clinical Pharmacology of
HIV and Hepatitis Therapy
June 8-10, 2016, Washington DC
Back grey_arrow_rt.gif
 
 
 
Efficacy of once-weekly MK-8591 in SIV infected rhesus macaques
 
 
  Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy; June 8-10, 2016; Washington, DC
 
J.A. Grobler1, D. Nicoll-Griffith, M.-T. Lai, K. Fillgrove, A. Lindauer, M.L. Rizk, D.J. Hazuda
 
1Merck Research Labs, Antiviral Research, West Point, USA
 
Long-Acting Oral and Parenteral Dosing of MK-8591 for HIV Treatment or Prophylaxis......http://www.natap.org/2016/CROI/croi_14.htm
 
  A Single Monotherapy Dose of MK-8591,a Novel NRTI, Suppresses HIV for Ten Days......http://www.natap.org/2016/CROI/croi_09.htm

Clin1

Clin2

Clin3

Clin4

Clin5

Clin6

Clin7

Clin8

Clin9

Clin10

Clin11

Clin12

Clin13